10,000 results · 71ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LYJ

FDA Adverse Event
Injury ·CYBERONICS, INC.·Product code LYJ·February 9, 2007

LEAD MODEL 302

FDA Adverse Event
Injury ·LIVANOVA USA, INC.·Product code MUZ·May 2, 2019

LEAD MODEL 303

FDA Adverse Event
Injury ·LIVANOVA USA, INC.·Product code MUZ·December 8, 2025

PROGRAMMING SOFTWARE

FDA Adverse Event
Malfunction ·CYBERONICS INC·Product code LYJ·January 23, 2014

PULSE GEN MODEL 103

FDA Adverse Event
Malfunction ·CYBERONICS, INC.·Product code LYJ·January 5, 2015

Stimulator, Autonomic Nerve, Implanted For Epilepsy

FDA classification
FDA Class 3 ·Stimulator, Autonomic Nerve, Implanted For Epilepsy

SenTiva, REF: 1000C, Generators Part of the VNS Therapy System with Microburst Stimulation. Used for Vagus Nerve Stimulation (VNS).

FDA Recall
Open, Classified ·LivaNova USA, Inc.·Product code LYJ·December 12, 2024

Cyberonics Vagus Nerve Stimulator VNS Therapy AspireSR Generator, Model 106

FDA Recall
Terminated ·Cyberonics, Inc·Product code LYJ·November 18, 2015

The LivaNova VNS Therapy System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS Therapy generator, lead, and external programming system used to change stimulation settings. The generator is an implantable, multi-programmable pulse generator that delivers electrical signals to the vagus nerve through the lead. The generator is housed in a hermetically sealed titanium case and is powered by a single battery. Electrical signals are transmitted from the generator to the vagus nerve by the lead. The lead and the generator make up the implantable portion of the VNS Therapy System. The VNS Therapy Programming System includes a computer pre-installed with VNS Therapy programming software and a programming wand. The physician uses the programming system to read and change generator settings. The Model 1000 Generator was commercially approved for distribution in the U.S. on October 3, 2017 via PMA P970003/S210.

FDA Recall
Open, Classified ·LivaNova USA Inc·Product code LYJ·November 16, 2018

Brand Name: SenTiva" Product Name: VNS Therapy" SenTiva", Model 1000 Model/Catalog Number: 1000 Software Version: NA Product Description: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS Therapy generator, lead, and external programming system used to change stimulation settings. The generator is an implantable, multi-programmable pulse generator that delivers electrical signals to the vagus nerve through the lead. The generator is housed in a hermetically sealed titanium case and is powered by a single battery. Electrical signals are transmitted from the generator to the vagus nerve by the lead. The lead and the generator make up the implantable portion of the VNS Therapy System. The VNS Therapy Programming System includes a computer pre-installed with VNS Therapy programming software and a programming wand. The physician uses the programming system to read and change generator settings. The Model 1000 Generator was commercially approved for distribution in the U.S. on October 3, 2017 via PMA P970003/S210. Component: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS).

FDA Recall
Open, Classified ·LivaNova USA, Inc.·Product code LYJ·January 3, 2025

VNS Therapy Demipulse Model 103 Generator Cyberonics, Inc. Houston, Texas, Model 103 Generators are provided in a sterile single use packages as part of the VNS Therapy System. Product labeling may be found at http://us.cyberonics.com/en/vns-therapy-for-epilepsy/healthcare-professionals/vns-therapy/manuals-page. Product Usage: The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents over 12 years of age with partial onset seizures, which are refractory to antiepileptic medications and for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments.

FDA Recall
Terminated ·Cyberonics, Inc·Product code LYJ·May 6, 2011

Brand Name: SenTiva DUO" Product Name: VNS Therapy SenTiva DUO", Model 1000-D Model/Catalog Number: 1000-D Software Version: NA Product Description: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS Therapy generator, lead, and external programming system used to change stimulation settings. The generator is an implantable, multi-programmable pulse generator that delivers electrical signals to the vagus nerve through the lead. The generator is housed in a hermetically sealed titanium case and is powered by a single battery. Electrical signals are transmitted from the generator to the vagus nerve by the lead. The lead and the generator make up the implantable portion of the VNS Therapy System. The VNS Therapy Programming System includes a computer pre-installed with VNS Therapy programming software and a programming wand. The physician uses the programming system to read and change generator settings. The Model 1000-D Generator was commercially approved for distribution in the U.S. on May 13, 2020 via PMA P970003/S231. Component: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS).

FDA Recall
Open, Classified ·LivaNova USA, Inc.·Product code LYJ·January 3, 2025

VNS Therapy Program GMDN: 44077 Model # 3000 V1.5.2, RxOnly

FDA Recall
Open, Classified ·LivaNova USA Inc·Product code LYJ·November 16, 2018

Cyberonics VNS Therapy AspireHC, Model 105 Generator. The Cyberonics VNS Therapy System consists of the implantable VNS Therapy Generator, the VNS Therapy Lead, and the external programming system used to change the stimulation settings. Indicated for use as an adjunctive therapy in reducing the frequency of seizures.

FDA Recall
Terminated ·Cyberonics, Inc·Product code LYJ·November 20, 2014

Model 104 VNS Therapy Demipulse Duo Generator Cyberonics, Inc. Houston, Texas, Model 104 Generators are provided in a sterile single use packages as part of the VNS Therapy System. Product labeling may be found at http://us.cyberonics.com/en/vns-therapy-for-epilepsy/healthcare-professionals/vns-therapy/manuals-page. Product Usage: The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents over 12 years of age with partial onset seizures, which are refractory to antiepileptic medications and for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments.

FDA Recall
Terminated ·Cyberonics, Inc·Product code LYJ·May 6, 2011

Cyberonics VNS Therapy Demipulse Duo Generator, Model 104; an implantable, multiprogrammable, vagus nerve stimulator.

FDA Recall
Terminated ·Cyberonics, Inc·Product code LYJ·February 7, 2008

Cyberonics Neuro Cyberonics Prosthesis System NCP Bipolar Lead, Model #300; Sterile, Single use only; Distributed by Cyberonics, Inc., Houston, TX 77058.

FDA Recall
Terminated ·Cyberonics, Inc·Product code LYJ·August 2, 2007

Cyberonics, VNS Therapy System Model 250 Handheld programming system using Dell x5 handheld and preprogrammed with software v7.1 and higher; manufactured by Cyberonics, Inc., Houston, TX.

FDA Recall
Terminated ·Cyberonics, Inc·Product code LYJ·October 25, 2007

SenTiva, REF: 1000; SenTiva Duo, REF: 1000-D; Generators Part of the VNS Therapy System. Used for Vagus Nerve Stimulation (VNS).

FDA Recall
Open, Classified ·LivaNova USA, Inc.·Product code LYJ·December 12, 2024

VNS Therapy SENTIVA DUO # 1000-D - Product Usage: indicated for the treatment of chronic or recurrent depression in patients who are experiencing a treatment-resistant or treatment- intolerant depressive episode.

FDA Recall
Terminated ·LivaNova USA Inc·Product code LYJ·November 12, 2020